ENTITY
HBM Holdings Limited

HBM Holdings Limited (2142 HK)

36
Analysis
Health CareHong Kong
HBM Holdings Limited operates as a biopharmaceutical company. The Company develops novel and highly differentiated antibody therapeutics in immunology and oncology disease areas. HBM Holdings provides its services throughout China.
more
Refresh
18 Feb 2021 01:03

Zhaoke Ophthalmology: Bringing Focus to China

Zhaoke Ophthalmology is a pre-revenue pharmaceutical company specializing in ophthalmic drugs for China that has filed to list on the HKEX. Lee's...

Share
01 Feb 2021 09:33

China Healthcare Weekly (Jan.29)

The article analyzed industry viewpoints in terms of IBD drug therapy, import substitution for reagent varieties and high-end antibiotics market,...

Logo
201 Views
Share
21 Dec 2020 09:45

China Healthcare Weekly (Dec.18)

The article analyzed the news about the negotiation result of PD-1/L1 in China VBP, industry viewpoints about radiotherapy and traditional Chinese...

Logo
429 Views
Share
13 Dec 2020 09:59

ECM Weekly (13 December 2020) - Vesync, Sino-Ocean, Jacobio, Netjoy, Sea, Xpeng, NIO, and More!

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
09 Dec 2020 17:38

HBM (和铂医药) IPO Trading: The Retail Retreat and the Vaccine News

HBM attracted a strong lineup of cornerstone investors but the sentiment is not as strong as previous hot deals. The company announced news in...

Logo
295 Views
Share
x